An Integration Move Drove The Viant Technology (DSP) Stock Higher

During the weekend session, the shares of Viant Technology Inc. (NASDAQ: DSP) increased 17.18%, concluding at $8.39. An integration approach drove the spike in Viant Technology’s shares.

A new integration between Viant Technology (DSP) and PurpleLab, a healthcare analytics firm with one of the biggest medical and pharmaceutical claims databases in the US, was unveiled. The goal of the integration was to provide healthcare marketers with an unmatched measuring solution.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Healthcare marketers urgently need a reliable measurement solution because the sector accounts for a sizeable 17% of the US GDP and healthcare spending on digital advertising is expected to increase at double-digit rates. Viant’s connection with PurpleLab offers access to closed-loop, de-identified measurement and reporting on a single platform, empowering healthcare brands and marketers.

Viant and PurpleLab are two companies that never stop innovating, especially when it comes to data, cookieless measurement, and analytics. With this integration, healthcare brands will be able to better optimize their campaigns and obtain insightful information about physician-level data, healthcare providers, and prescription optimization.

Viant’s connection with PurpleLab will enable it to provide marketers sophisticated healthcare insights. PurpleLab’s vast claims database, HealthNexus, their proficiency in assessing provider performance, and Viant’s cookieless Household ID will all be utilized.

The end product will be an intricate and all-encompassing measuring system that combines physician-level data, healthcare providers (HCP), and prescription optimization.

Through the integration, healthcare brands and marketers will have access to a cutting-edge measurement solution, allowing them to improve patient outcomes in the healthcare sector, change campaign messaging, target audiences more successfully, and make smarter decisions.

Viant Technology was recently declared the winner of the Business Intelligence Group’s 2024 BIG Innovation Awards. The AI Product Suite from DSP took first place in the Internet and Technology category.

Viant’s artificial intelligence technology aims to propel its platform closer to its vision of autonomous advertising. Its artificial intelligence technology aims to make the daily complexity faced by programmatic trading simpler.

Its products, such as Viant’s Chat with Data, break down barriers by using natural language instructions in place of complicated code specifications to activate first-party data and enhance campaign effectiveness and performance. This is what autonomous advertising promises to do.

Most Popular

Related posts